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Rat ventricular myocytespendent inward current generated by the hyperpolarization-activated cyclic
nucleotide-gated (HCN) channels contributes to the tissue-speciﬁc rhythmic activities in the brain and heart.
Four isoforms (HCN1–HCN4) have been identiﬁed. Previous studies showed that different HCN isoforms may
form functional heteromeric channels. We report here that when HCN2 and HCN4 mRNA were injected into
Xenopus oocytes with various ratios of HCN2 over HCN4 at 1:1, 10:1, and 1:10, respectively, the resultant
channels showed a depolarized current activation and signiﬁcantly faster activation kinetics near the
midpoint of activation compared with HCN4 homomeric channels. In adult rat myocytes overexpressing
HCN4, there was an associated increase in HCN2 mRNA. In neonatal rat myocytes in which HCN2 was
knocked down, there was also a simultaneous decrease in HCN4 mRNA. Coimmunoprecipitation experiments
showed that HCN2 and HCN4 channel proteins can associate with each other in adult rat ventricles. Finally, in
adult myocytes overexpressing HCN4, the hyperpolarization-activated inward current activation, If, was
shifted to physiological voltages from non-physiological voltages, associated with faster activation kinetics.
These data suggested that different ratios of HCN2 and HCN4 transcripts overlapping in different tissues also
contribute to the tissue-speciﬁc properties of If.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionHyperpolarization-activated current, Ih or If, contributes to many
cellular functions such as resting membrane potential, synaptic
transmission, and rhythmic activity in neurons and myocytes [1].
One of the unique features about this current is its distinct properties
in different tissues [1]. The current is generated by the hyperpolariza-
tion-activated cyclic nucleotide-gated (HCN) pacemaker channels.
Four isoforms (HCN1–4) have been identiﬁed [2–4]. Each isoform
exhibits different gating properties when expressed in heterologous
expressing systems such as Xenopus oocytes and HEK293 cells [2–4].
In many areas HCN channels are differentially expressed with
overlap [1]. This raised a question for possible in vivo formation of
HCN heteromeric channels. It has been reported that HCN1 and HCN2
can form a functional heteromeric channel in Xenopus oocytes [5,6]
and mammalian cells (HEK293 and CHO cells) [7,8] as well as in
neurons [5,6]. HCN1 and HCN4 were also shown to function as a
heteromeric channel in sinoatrial node (SAN) cells [9]. Recently, HCN2
and HCN4 have been reported to co-assemble and form functional
heteromeric channels in HEK293 and CHO cells, mouse embryonic
heart, and rat thalamus [10,11].
In cardiac myocytes, If is the pacemaker current critical to the
initiation and regulation of cardiac pacemaker activity [12]. Three HCN304 293 5513.
ll rights reserved.channel isoforms, HCN1, HCN2 and HCN4, are non-uniformly
expressed in heart. All three are present in SAN cells with HCN4
being the prevalent form, whereas higher HCN2 and lower HCN4 have
been detected in ventricles [13]. Interestingly, the ratio of HCN2 over
HCN4 transcript changes from 5:1 in the neonate to 13:1 in the adult,
which is accompanied with a hyperpolarizing shift of If activation [13].
It remains an open question whether the ratio of HCN2 and HCN4
transcripts is a contributing factor to changes in the biophysical
properties of If in ventricular myocytes. Moreover, it has not been
reported whether HCN2 and HCN4 channel proteins can associate
with each other in cardiac ventricularmyocytes. The present workwas
designed to address these questions.
2. Methods
2.1. Heterologous expression of HCN2 and HCN4 in Xenopus oocytes
Oocytes were prepared from stage V mature female Xenopus laevis
as previously described [14]. Oocytes were injected with 50 nl of cRNA
(0.1 ng/nl)made frommouse HCN2 and humanHCN4 cDNA plasmids.
Injected oocytes were incubated at 18 °C for 24–96 h prior to voltage
clamp recordings. For electrophysiological studies, oocytes were
voltage-clamped using a two-microelectrode voltage clamp setup.
The holding potential was −30 mV. The extracellular recording
solution contained (mM): 80 NaCl, 2 KCl, 1 MgCl2, and 5 Na-HEPES
(pH 7.6). The threshold activation of current was deﬁned as the least
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the noise with amplitude no less than 10–20 pA.
2.2. Heterologous expression of HCN2 and HCN4 in HEK293 cells
Mouse HCN2 cDNA in oocyte expression vector, pGH, was
initially obtained from Drs. Bina Santoro/Steve Siegelbaum (Colum-
bia University). We subcloned it into the EcoRI/XbaI sites of
pcDNA3.1 mammalian expression vector (Invitrogen) for functional
expression in mammalian cells. Human HCN4 cDNA was originally
provided as a gift by Dr. U.B. Kaupp (Institut für Biologische
Informationsverarbeitung, Germany). We subcloned it into the
HindIII/Xba sites of pcDNA3.1.
HEK293 cells were grown in Dulbecco's modiﬁed Eagle's medium
(DMEM, Invitrogen), supplemented with 10% fetal bovine serum,
100 IU/ml penicillin, and 100 g/l streptomycin. Cells with 50–70%
conﬂuence in 6-well plate were used for HCN2 and HCN4 plasmids
transfection using Lipofectamine2000 (Invitrogen). HCN was co-
transfectedwith GFP for easy selection of cells for patch clamp studies.
2.3. Whole-cell patch clamp recordings of HCN in HEK cells and in If in
myocytes
After 24–96 h transfection cells with green ﬂuorescence were
selected for patch clamp experiments. The HEK293 cells were
placed in a Lucite bath in which the temperature was maintained at
25 °C±1 °C by a temperature controller (Cell MicroControls, VA).
If/IHCN currents were recorded using the whole-cell patch clamp
technique with an Axopatch-200B ampliﬁer. The pipettes had a
resistance of 2–4 MΩ when ﬁlled with internal solution (mM: NaCl
6, K-aspartate 130, MgCl2 2, CaCl2 5, EGTA 11, and HEPES 10; pH
adjusted to 7.2 by KOH). The external solution contains (mM) NaCl
120, MgCl2 1, HEPES 5, KCl 30, CaCl2 1.8, and pH was adjusted to 7.4
by NaOH. The Ito blocker, 4-AP (2 mM), was added to the external
solution to inhibit the endogenous transient potassium current,
which can overlap with and obscure IHCN tail currents recorded at
+20 mV. Datawere acquired by CLAMPEX and analyzed by CLAMPFIT
(pClamp 8, Axon).
Due to slow activation kinetics of HCN4, currents elicited by
hyperpolarizing pulses near the threshold activation of the channel
(e.g., −85 mV to −105 mV) did not reach steady states even in
response to the 20-second pulses. We thus ﬁt the current traces to the
steady states with an exponential function. We then divided the
amplitude of the steady state current trace by that measured from 20-
second current amplitude and obtained a ratio (always greater than
1). We then multiplied this ratio to the corresponding tail currents
which were then used to construct the activation curves.
The freshly isolatedmyocytes were placed in a Lucite bath inwhich
the temperature was maintained at 35 °C±1 °C by a temperature
controller (Cell MicroControls, VA). If currents were recorded using
the whole-cell patch clamp technique with an Axopatch-700B
ampliﬁer (Axon). The external solution contained (mM) NaCl 140,
KCl 5.4, CaCl2 1.8, MgCl2 1, and Glucose 10, NiCl2 0.1, BaCl2, 5, 4-AP 2,
TTX 0.03, pH 7.4. The pipettes had a resistance of 2–4 MΩ when ﬁlled
with internal solution composed of (mM) NaCl 6, K-aspartate 130,
MgCl2 2, CaCl2 1, Na2-ATP 2, Na-GTP 0.1, HEPES 10, pH 7.2. Sodium (INa)
and potassium (Ito) current blockers, tetrodotoxin (TTX) and 4-
aminopyridine (4-AP), were added to the external solution to inhibit
the sodium and transient potassium currents. During If recording,
BaCl2 was added to the external solution to block IK1 background
potassium current which can mask If current.
Data are shown as mean±SEM. The threshold activation of If is
deﬁned as the ﬁrst hyperpolarizing voltage at which the time-
dependent inward current can be observed. Student's t-test and one-
way ANOVA were used for statistical analysis. pb0.05 was considered
as statistically signiﬁcant.The patch clamp setup is also equipped with bright-ﬁeld and
ﬂuorescent light sources. It also has CCD camera attached to take
either bright-ﬁeld or ﬂuorescent image of the same batch of myocytes.
2.4. Cardiac tissue and myocyte preparation
Adult (300–350 g, about 3 month old) and neonatal (days 1–3) rats
were euthanized by intraperitoneal injection of pentobarbitol in
accordance with the Institutional Animal Care and Use Committee
protocols. The heart was excised and ventricles were cut out and
prepared for protein chemistryexperiments, as previously reported [15].
The adult rat ventricular myocytes were prepared using a
collagenase dissociation protocol as previously described [15,16].
Brieﬂy, the aorta was cannulated and the heart was retrogradely
perfused with oxygenated Ca2+-free Tyrode solution at 37 °C for
5 min, followed by oxygenated Ca2+-free Tyrode solution containing
0.6 mg/ml collagenase II (Worthington Biochemical) for 20–30 min.
The ventricles were minced into small pieces in KB solution,
dispersed, and ﬁltrated through a 200 μm mesh.
The neonatal rat ventricular myocytes were prepared using a
modiﬁed method as previously described [17]. Brieﬂy, whole hearts
were minced in Ca2+- and Mg2+-free D-Hanks solution (mM):
KH2PO4 0.06, NaCl 8.0, NaHCO3 0.35, KCl 0.4, Na2HPO4 0.05. The
myocardial cells were dispersed by the addition of Hanks solution
containing trypsin 0.1% and then were stirred at 37 °C. The
supernatant was removed and discarded. Cells were incubated with
fresh trypsin 0.1% for 20 min at 37 °C. The supernatant was collected,
and cells were isolated by centrifugation in a tabletop centrifuge for
5 min at 1000 rpm at room temperature. Cells were resuspended in
5 ml DMEM supplemented with 10% fetal bovine serum and kept at
37 °C. The digestion stepwas repeated four times, and cell suspensions
from each digestion were combined and centrifuged at 1000 rpm for
5 min. Cells were then resuspended in DMEM (1.8 mM Ca2+)
supplemented with 10% horse serum, 5% FCS, 0.1 mmol/l 5-bromo-
deoxyuridine and 1% antibiotics (10,000 U/ml penicillin and
10,000 μg/ml streptomycin). The myocyte-enriched suspension was
transferred to culture dishes at a density of approximately 1.5×106
cells per 60-mm culture dish.
2.5. Co-immunoprecipitation
Total protein extracts were prepared from heart tissues using
CytoBuster Protein Extraction Reagent (Novagen). The protein con-
centration of the lysate was determined using the Bradford method.
Equal amounts of total protein (1.0 g) were incubated with a speciﬁc
antibody for 1 h at 4 °C, and protein A/G PLUS-agarose (Santa Cruz)
was then added and incubated overnight with gentle rock. The beads
were washed extensively with cold PBS buffer, and resuspended in 2×
Laemmli sample buffer. The immune complexes were separated by
SDS-PAGE and analyzed by Western blot using an anti-HCN4 or an
anti-HCN2 polyclonal antibody (Alomone).
2.6. Viral transduction of cardiac myocytes
2.6.1. Cell culture for adult and neonatal rat ventricular myocytes
Freshly isolated adult rat myocytes were suspended in culture
media M199 supplemented with 0.2% albumin, 5 mM taurine, 3.0 mM
creatine, 3.0 mM carnitine, 0.1 μM insulin and 1% antibiotics (100 IU/
ml penicillin, 50 IU/ml streptomycin, Sigma). After counting the cells
using a hemocytometer, approximately 3×105 cells were plated in
each well of the 6-well plates that were pre-coated with laminin
(Sigma) 24 h prior to the myocyte isolation and kept in cell culture
incubator at 37 °C. The cells were allowed to attach for 1 h and then
the media was changed with fresh culture media to remove
unattached myocytes. The isolated cells were further cultured for
1 h before infection.
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ﬁbroblast proliferation, cultured initially in serum-containing med-
ium, and then switched to serum-free medium after 24 h. Most
ﬁbroblast cells were removed by collecting neonatal myocytes in the
supernatant within 1–2 h after isolation. Myocytes were cultured in
DMEM-Medium199 (4:1) supplementedwith 5% FBS, 5% horse serum,
1% L-glutamine and 1% penicillin/streptomycin. Myocytes were
treated with mitomycin C (0.1–1 μM) to prevent further ﬁbroblast
cell growth. Final cell populations contained more than 95% growth-
arrested cardiomyocytes, as assessed by immunoﬂuorescence
analysis.
For infection, the lentivirus stock was applied at MOI (multiplicity
of infection)=10 in the presence of 8 μg/ml polybrene (Sigma).
Empty lentivirus was used in parallel to infect myocytes as a negative
control. All subsequent experiments were carried out at 48–72 h after
infection. The infection efﬁcacy was higher in neonatal (N95%) than in
adult ventricular myocytes (N80%).
2.6.2. Design of HCN2-shRNA and subcloning HCN2-shRNA and HCN4
into lentiviral vectors
For small-hairpin RNA design for HCN, three shRNA nucleotides (1.
TCCAGGAGATTGTCAAATGTGACTGT, 2 . CGTGGTTTCGGA-
TACTTTCTTCCTCA, 3. CGCACCGGCATTGTTATTGAGGACAA) against
the rat/mouse HCN2 gene (designed by using Invitrogen online
shRNA designing tool) were inserted into BamHI/EcoRI site of
lentivirus vector pSIF1-H1-copGFP (SBI, Mountain View, CA). These
three constructs were designated as HCN2-shRNA-1, HCN2-shRNA-2,
and HCN2-shRNA-3. HCN2-shRNA-2 achieved the inhibitory effect of
N90%. HCN2-shRNA-1 achieved inhibitory effect of about 80%). HCN2-
shRNA-3 did not have signiﬁcant inhibitory effect. We used HCN2-
shRNA-2 throughout the following experiments inmyocytes, and used
name HCN2-shRNA. The shRNA constructs were co-transfected with
recombinant plasmid pcDNA3.1/myc-His containing mHCN2 gene to
screen their efﬁcacy in HEK293 cells. As a negative control, pSIF1-H1-
siLuc-copGFP (target luciferase) was co-transfected with the target
recombinant plasmids. After 48–72 h incubation, cells were harvested
and total protein extracts were prepared. Real time RT-PCR and
Western blot analysis were carried out to select the effective
construct. The functional efﬁcacy of HCN2-shRNA was further tested
and conﬁrmed using whole-cell patch clamp in HEK293 cells
expressing HCN2 channels.
Full-length of human HCN4 cDNA was subcloned into Xba I site of
pCDF1-MCS2-EF1-copGFP™ (SBI) to generate plasmid pCDF1-hHCN4.
Correct insert in the desired orientation was veriﬁed by restriction
digest and DNA sequencing.
2.6.3. Lentivirus production
HEK293TN (SBI) cells were seeded in 10-cm plate the day before
transfection. When cells reached 50–70% conﬂuence, cells were co-
transfected with 10 μg of the Packaging Plasmid Mix (SBI) and 2 μg
HCN2-shRNA or hHCN4 using Lipofectamine™/Plus™ Reagent (Invi-
trogen). Supernatants at 48–72 h post transfectionwere collected and
centrifuged at 3000 rpm for 5 min to pellet cell debris and ﬁltered the
supernatant through Millex-HV 0.45 μm PVDF ﬁlters (Millipore).
Lentiviral pseudovirus was concentrated using PEG-it™ Virus Pre-
cipitation Solution (5X, SBI) and stored at−80 °C. Titer estimation of
lentivirus was subsequently carried out by Fluorescence-activated
cell-sorting (FACS) analysis.
2.7. Test of HCN2-shRNA in HEK293 cells
To test the speciﬁcity of shRNA-HCN2, HEK293 cells with 90–95%
conﬂuence in 96-well plate were co-transfected with pcDNA3.1-
HCN4 and shRNA-HCN2 (SBI). As a negative control, empty vector
pSIF1-H1-copGFP was also co-transfected with pcDNA3.1-HCN4 at
the same time. 18–24 h after transfection, total RNA was extractedand transcribed reversely into cDNA using Cells-to-cDNA II kit
(Ambion).
2.8. Real-time RT-PCR
Total RNA was isolated from same amount (∼105) and same
incubation time (48–72 h) of infected myocyte cells using RNAqu-
eous-4PCR kit (Ambion) and transcribed reversely into cDNA with
High Capacity cDNA Reverse Transcription Kit. Relative quantiﬁcation
of HCN2 and HCN4 mRNA was performed on 1.5 μl of each cDNA
preparation using Universal TaqManMasterMix (Applied Biosystems)
and TaqMan® Gene Expression Assays (Applied Biosystems, Assay ID:
Rn01408575_gH for HCN2, Assay ID: Hs00175760_m1 and
Rn00572232_m1 for HCN4) in an ABI HT7900 Sequence Detection
System. The TaqMan Assay targeting 18S rRNA (Applied Biosystems,
Assay ID: Hs99999901_s1) was used as an endogenous control to
normalize differences in RNA input. After conﬁrmation that the
ampliﬁcation efﬁciency of HCN genes and the endogenous control 18S
rRNA were approximately equal, differences were calculated with the
threshold cycle (Ct), and the comparative Ct method was used for
relative quantiﬁcation [18].
3. Results
3.1. Functional expression of HCN2 and HCN4 in Xenopus oocytes and in
HEK cells
We ﬁrst tested the idea that oocytes injected withmixed HCN2 and
HCN4 mRNA might express resultant channels with gating properties
different from HCN2 or HCN4 homomeric channels if HCN2 and HCN4
indeed form heteromeric channels.
Fig. 1 shows the currents recorded from oocytes 48 h after
injection. Ratio of HCN2 over HCN4 mRNA used for injection was 1:10
(A), 1:1 (B), and 10:1 (C), respectively. HCN2 (D) and HCN4 (E) mRNA
were also injected separately to serve as controls. Hyperpolarizing
pulses from −55 mV to −115 mV in 10 mV increment for 8 s were
applied (A–C). Hyperpolarizing pulses from−65mV to−115mV and
−75 mV to −135 mV for 7 s were used for HCN2 and HCN4,
respectively. To analyze the gating properties, we constructed the
activation curve by dividing the tail currents recorded at +10 mV
(Etest) by the driving force (Etest-Erev, the reversal potential in each
oocyte was measured). For slow activation of HCN2 and HCN4 around
the midpoint of current activation (whether individually expressed or
coexpressed), we applied longer pulses (an illustration is provided in
Fig. 1F) to obtain the current traces that allow us to perform
Boltzmann best ﬁt with single exponential function.
Fig. 2 shows the voltage-dependent activation kinetics (A–E) and
the midpoint activations (V1/2) (F). In comparison to HCN2 (1:0) or
HCN4 (0:1) homomeric channels, mixed HCN2/HCN4 channels all
exhibited a depolarizing shift in voltage-dependent activation.
Averaged V1/2 of HCN2/HCN4 was −94±2 mV, −104±2 mV,
−82±3mV,−86±2mV,−84±3mV for ratios of 1:0, 0:1, 1:10, 1:1,
and 10:1, respectively. The slope factors were not signiﬁcantly altered
(7.4±0.6, 8.8±0.8, 8.4±0.5, 7.8±0.6, 7.5±0.9, for 1:0, 0:1, 1:10, 1:1,
and 10:1, respectively).
The voltage-dependent activation of HCN2 and HCN4 has been
studied in HEK293 cells and different values for midpoint activation
of HCN2 and HCN4 have been reported [19–23]. Fig. 3 shows the
current expression of HCN2 (A) and HCN4 (B) subcloned in pcDNA3
(a widely used vector for exogenous protein expression in mamma-
lian context) under our experimental conditions. The midpoint
activation were −83±4 mV (n=5) for HCN2 and −90±3 mV
(n=5) for HCN4. Since we focused on the potential contribution of
relative mRNA ratio of HCN2 over HCN4 to the voltage-dependent
activation of the heteromeric channels, we will not consider the
post-translational modulation of HCN channels (e.g., protein
Fig. 1. Functional co-expression of HCN2 and HCN4 in Xenopus oocytes. HCN2 and HCN4 mRNA at the ratio of 1:10 (A), 1:1 (B), and 10:1 (C) were injected into oocytes. The resultant
channel currents were elicited by 8-second hyperpolarizing pulses ranging from−55 mV to−115 mV in 10mV increment and stepped back to 10 mV for recording tail currents. (D)
Expression of HCN2 alone in oocytes. The current trace at −55 mV was not shown due to no activation until −75 mV. (E) Expression of HCN4 alone in oocytes. The more
hyperpolarized pulses (−75 mV to−135mV in 10mV increments) were used to reﬂect the more negative activation of HCN4. The holding potential was−30 mV. One current trace
without activationwas kept in panels A–D to emphasize the threshold activation at the next voltage. (F) Illustration of Boltzmann best ﬁt with one exponential function on slow HCN
currents (dark lines) activated by 60 second hyperpolarizing pulses from−65 mV to−95 mV to allow full current activation. The red lines were the ﬁt curves after initial delay in
current activation.
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mediated kinases [27,28]) that can dramatically affect the gating of
HCN2 and HCN4 expressed in HEK293 cells.
The voltage-dependent current activation kinetics showed that
HCN2/HCN4 at all ratios activated signiﬁcantly faster than HCN4
homomeric channels (Fig. 2E), but not HCN2 channels (Fig. 2D). The
voltages at which the slowest activation occurred were shifted to
depolarized potentials, consistent with the positive shift in midpoint
activation (n=7–12). These data suggested that mixture of HCN2 and
HCN4 mRNA can produce the resultant functional channels with
gating properties different from their homomeric channels, which
favors the hypothesis for the possible formation of functional
heteromeric channels.
Given that the transcript levels for HCN2 and HCN4 are different in
ventricles and change during development [29], we decided to
examine the mRNA levels of one isoform when that of the other is
altered.
3.2. Linked decrease in HCN4 mRNA with inhibited HCN2 mRNA in
neonatal rat myocytes
Due to relatively higher HCN2 and HCN4 transcripts in neonatal
than in adult rat ventricles, we ﬁrst tested the hypothesis that
inhibiting mRNA levels of one isoform may alter that of the other. We
designed several small hairpin RNA (shRNA) nucleotides that
speciﬁcally targeted a mouse HCN2 gene, inserted them into ashRNA-expressing lentiviral vector. We screened these nucleotides
for their efﬁcacy in knocking downHCN2 expression at levels of mRNA
and protein and ionic currents by co-transfecting them respectively
with a target gene into HEK293 cells [30].
Fig. 4 shows a typical set of experiments performed to test the
efﬁcacy of inhibition of HCN2 channel activity in HEK293 cells. First,
we examined the changes in HCN2 mRNA (normalized to 18S) by
HCN2-shRNA using RT-PCR (Fig. 4A). The left panel shows
85.0±1.5% (n=5, pb0.05) inhibition of HCN2 mRNA. The empty
vector was used as a control. Second, we performed Western
blotting analysis to conﬁrm that a signiﬁcant reduction of HCN2
channel protein was accompanied with its mRNA decrease. Indeed,
Fig. 4B shows that HCN2-shRNA inhibited the HCN2 signal in
comparison to the cells transfected HCN2 alone or the empty
vector. HCN4 transfected or non-transfected (NT) HEK293 cells
were used as a speciﬁcity control for HCN2 antibody and a negative
control, respectively. The averaged inhibition was 84.0±1.4% (n=5,
pb0.05) (right panel of Fig. 4A). Inhibited HCN2 at both mRNA and
protein levels indicated a classical RNAi mechanism by HCN2-
shRNA. Finally, we tested functional efﬁcacy of HCN2-shRNA
inhibition by recording the HCN2 current in HEK293 cells expres-
sing HCN2 channels. The functional current expression of HCN2 was
not affected by empty vector transfection (Fig. 4C), but nearly
blocked by co-transfecting HEK293 cells with HCN2-shRNA (Fig.
4D). The mean IHCN2 measured at −95 mV was reduced by 96±1%,
n=5, pb0.05 (Fig. 4E).
Fig. 2. Gating properties of co-expressed HCN2/4 channels. Voltage dependent activation kinetics for HCN2/HCN4 channels at ratios of 1:10 (A),1:1 (B), 10:1 (C),1:0 (D), and 0:1 (E),
respectively. (F) Averaged midpoint activation of mixed HCN2 and HCN4 channels as compared to HCN2 and HCN4 homomeric channels. Symbols ⁎, &, and $ indicated statistical
signiﬁcance for the corresponding pairs (pb0.05).
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rat ventricular myocytes (NRVM) mediated by lentivirus. Fig. 5A
shows images before (brightﬁeld) and after (ﬂuorescence) lentiviral
infection of the same neonatal rat ventricular myocytes, indicating
that most, if not all, myocytes can be effectively infected by lentivirus
which is tagged by GFP. Fig. 5B shows that the HCN2 mRNA level was
inhibited by 88±3% (n=5, pb0.05) with HCN2-shRNA. Infection of
empty viral vector tagged with GFP itself had little effect on HCN2
mRNA levels. However, there was an associated down-regulation of
HCN4 mRNA (62±6%, n=5, pb0.05), which is in comparison to the
control experiment that the infection of empty viral vector tagged
with GFP had little effect on HCN4 mRNA levels (Fig. 5C). To exclude
the potential off-target effect of HCN2-shRNA nucleotides on HCN4
mRNA, we examined the potential inhibition of HCN2-shRNA on
HCN4, an isoform in the same family. In cells overexpressing HCN4,
little effect (92±8%, n=3, pN0.05) of HCN2-shRNA on HCN4 mRNA
was observed as compared to the control (GFP-tagged empty vector
infection) (Fig. 5D). The protein expression level of HCN4 was not
affected, either (Fig. 5E). Western blot experiment was repeated at
least three times.
3.3. Linked increase in HCN2 mRNA with increased HCN4 mRNA in adult
rat ventricular myocytes
We next tested the idea that increasing mRNA of one isoform may
increase mRNA of the other. We subcloned a human HCN4 gene into
the lentiviral vector and infected adult rat myocytes (see Methods for
details). Fig. 6A shows the images before (bright-ﬁeld) and after
(ﬂuorescence) lentiviral infection in the samemyocyte. RT-PCR results
show that the levels of the endogenous rat HCN4 (rHCN4)mRNAwere
increased by 2.8±0.7 fold (n=5, pb0.05)) (Fig. 6B). Interestinglyagain, the endogenous rat HCN2 (rHCN2) mRNA levels were also up-
regulated by 4.3±0.8 fold (n=5, pb0.05) (Fig. 6C).
3.4. Association of HCN2 and HCN4 channel proteins in adult rat
ventricular myocytes
In combination of the functional expression studies of mixed HCN2
and HCN4 channels that favored the formation of heteromeric
channels in oocytes and associated change in transcript of one
isoformwhile themRNA level of the other is changed inmyocytes, it is
likely that the HCN2 and HCN4 channel proteins are associated in
adult rat ventricular myocytes.
Fig. 7 shows that the ventricular sample was ﬁrst immunopreci-
pitated using a speciﬁc anti-HCN4 antibody, and the HCN2 signal was
then detected using a speciﬁc anti-HCN2 antibody (Fig. 7A). There are
two HCN2 bands (one near 100 kDa and the other near 112 kDa)
representing the glycosylated (mature) and unglycosylated forms
[10]. If the samplewas ﬁrst immunoprecipitated using a speciﬁc HCN2
antibody, the HCN4 signals were readily detected with an HCN4
antibody (Fig. 7B). Samples immunoprecipitated using the same
antibody and non-transfected HEK293 cells (marked Control) were
used as a positive control and a negative control, respectively. The
speciﬁcities of HCN2 and HCN4 antibodies have been previously
tested [15,24,31]. The results supported the notion that HCN2 and
HCN4 proteins can associate with each other in adult rat ventricles.
3.5. If in adult rat ventricular myocytes overexpressing HCN4
If the ratio of HCN2 over HCN4 transcript is also a contributing
factor to the voltage-dependent activation of If, an altered ratio of
HCN2 over HCN4 should change If. We have previously shown that the
Fig. 3. Expression of HCN2 and HCN4 in HEK cells. (A) HCN2 currents were elicited by hyperpolarizing pulses with variable durations from −55 mV to −125 mV in 10 mV
increments. (B) HCN4 currents were elicited by 20 s hyperpolarizing pulses from−75 mV to−135 mV in 10 mV increments. The holding potential was−10 mV. Tail currents were
recorded at +20 mV.
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adult, accompanied with a hyperpolarized shift of If activation [13]. If
we increase the ratio by increasing HCN4 in adult rat ventricles, which
will decrease the HCN2/HCN4 ratio, we would expect to observe a
depolarized shift of If activation.
Fig. 8 provided a typical set of protein biochemistry and
electrophysiological data showing an increased expression of HCN4
and an altered If after we over-expressed HCN4mediated by lentivirus
(see Methods for details). Fig. 8D showed that HCN4 proteins were
barely detected (non-infected lane) byWestern blot analysis due to its
low expression in adult rat ventricle [13]. But the signals can be readily
detected for myocytes overexpressing HCN4 (in three samples). TheFig. 4. shRNA inhibition of HCN2 channels in HEK293 cells. (A) Quantitative shRNA inhibition
by normalization of mRNA to 18S. Protein quantiﬁcationwas carried out by normalization of
in cells co-transfectedwith HCN2 and the empty vector, with HCN2 and HCN2-shRNA, andwi
by HCN2 and empty vector. HCN2 current was activated by a 3-second hyperpolarizing puls
HCN2 and HCN2-shRNA. HCN2 current was activated by a 3-second hyperpolarizing pulse to
control and HCN2-shRNA.associated increase in If current expression was shown in Fig. 8B. The
currents were elicited by 4.5-second hyperpolarizing pulses from
−70 mV to−140 mV (Fig. 8A, C) or variable pulse durations (Fig. 8B)
in 10 mV increments. The tail currents were recorded at +20 mV. To
verify the enhanced time-dependent inward current was indeed If, we
applied 4 mM Cs to block it shown in the inset of Fig. 8B. The current
density measured at −120 mV or −125 mV was 5.6±1.9 pA/pF
(n=8) for HCN4-infected myocytes, 0.9±1.1 pA/pF (n=10) for non-
infected myocytes (Fig. 8A), and 0.7±0.8 pA/pF (n=5) for vector-
infected myocytes (Fig. 8C). The increased If current density is
statistically signiﬁcant in comparison to either non-infected or
vector-infected myocytes (pb0.05). There is no statistical differenceof HCN2mRNA (left panel) and protein (right panel). RNAQuantiﬁcationwas calculated
protein to β-actin. (B) Immunoblots of HCN2 signal detection by an anti-HCN2 antibody
th either HCN4 only or non-transfection, respectively. (C) HEK293 cells were transfected
e to−95 mV from a holding potential of −10 mV. (D) HEK293 cells were affected by
−95 mV from a holding potential of−10 mV. (E) Mean current density of HCN2 in the
Fig. 5. Association of reduced HCN2 and HCN4 mRNA in neonatal rat ventricular myocytes and controls in HEK293 cells. Neonatal rat ventricular cardiomyocytes were infected by
GFP-tagged lentivirus containing shRNA speciﬁcally targeted to HCN2. (A) Bright-ﬁeld (left panel) and ﬂuorescent (right panel) images of NRCM. Scale bar=10 μm. (B) Reduced
HCN2mRNA by RNAi. (C) Reduced HCN4mRNA by HCN2 RNAi. Empty vector infection did not signiﬁcantly affect the HCN2 or HCN4mRNA. (D) HCN2-shRNA did not affect mRNA of
HCN4 expressed in HEK293 cells. HCN4 mRNAwas then measured by RT-PCR after 24 h transfection in cells with and without transduction of lentivirus containing HCN2-shRNA. (E)
HCN2-shRNA did not affect protein expression of HCN4 expressed in HEK293 cells.
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myocytes. Lentivirus infection of myocytes did not cause signiﬁcant
morphological change in myocytes.
Accompanying the increased current amplitudewas a positive shift
in If threshold activation which was −80 mV (arrow) (Fig. 8B). The
non-infected myocyte (Fig. 8A) or vector infected myocyte (Fig. 8C)
shows If with threshold activation around −100 mV (arrow),
consistent with our previous reports [16,29]. Averaging over 5–10
myocytes for each group, the threshold for If activation was
−107±8 mV (n=10) for non-infected myocytes, −76±9 mV
(n=8) for HCN4-infected myocytes, and −110±7 mV (n=5) for
vector infected myocytes.
In addition, If kinetics was also accelerated in HCN4-infected
myocytes. At −120 mV or −125 mV, the time constants of current
activation were 1.47±0.48 s (n=10) for control and 0.47±0.18 sFig. 6. Association of increased HCN2 and HCN4 mRNA in adult rat myocytes. (A) Bright-ﬁe
myocyte infected by GFP-tagged lentivirus containing HCN4. Scale bar=20 μm. (B) Increased
overexpressing HCN4. Empty virus infection did not signiﬁcantly affect the HCN2 or HCN4(n=8) for HCN4-infected myocytes, and 1.69±0.52 s (n=5) for
vector-infected myocytes.
4. Discussion
Using a combination of electrophysiology and biochemistry as well
as ﬂuorescent imaging techniques, formation of functional hetero-
meric HCN channels has been investigated for HCN1/HCN2 [5–8],
HCN1/HCN4 [9], HCN2/HCN4 [10,11]. Evidence also showed that
HCN2 and HCN3 do not associate with each other when they were
expressed in HEK293 cells [10].
In this study we presented evidence showing the different
properties of HCN2/HCN4 channels expressed in Xenopus oocytes
from their respective homomeric channels — some of them were
unexpected. When HCN2 and HCN4 were expressed in Xenopusld image (upper panel) and ﬂuorescent image (lower panel) of an adult rat ventricular
HCN4mRNA inmyocytes overexpressing HCN4. (C) Increased HCN2mRNA inmyocytes
mRNA, shown as Control.
Fig. 7. Association of HCN2 and HCN4 in adult rat ventricles. (A) HCN2 signal detection in samples immunoprecipitated using a HCN4 antibody. HCN2 signal detection in samples
immunoprecipitated using the same HCN2 antibody was used as a positive control. (B) HCN4 signal detection in samples immunoprecipitated using a HCN2 antibody. HCN4 signal
detection in samples immunoprecipitated using the same HCN4 antibody was used as a positive control. HEK293 cells with no transfection of HCN2 and/or HCN4 were used as
negative controls for (A) and (B), respectively.
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negative threshold activation and faster activation kinetics in
comparison to HCN4 [14,26]. We therefore anticipated only three
outcomes if HCN2 and HCN4 channels gate independently when
expressed in oocytes: (1) mixing mRNAs of HCN2 and HCN4 equally
(1:1) would generate the channels having intermediate properties —
current activation more negative than HCN2 but more positive than
HCN4 with activation kinetics slower than HCN2 but faster than
HCN4; (2) mixing more HCN2 mRNA with HCN4 (10:1) would
generate the channels with gating properties very close to that of
HCN2; (3) mixing more HCN4 mRNA with HCN2 (1:10) would
generate the channels gating properties very close to HCN4. However,
our data showed that all ratios of HCN2 and HCN4 mRNAs resulted in
the activation at more depolarized potentials with generally faster
activation. The fastest activation was observed surprisingly in
channels with a ratio of 0.1, which was predicted to be very close to
activation of HCN4 homomeric channels. These results suggested the
functional formation of HCN2/HCN4 heteromeric channels which are
not simple summation of their respective homomeric channels. They
are indicative of the likely results of different modulation of the
heteromeric channels as compared to that for homomeric channels.
Interestingly, previous studies of HCN1/HCN2 in Xenopus oocytes
showed intermediate properties which also led to the conclusion of
heteromeric channels [5,6].Fig. 8. If in adult rat ventricular myocytes without (A) or with empty lentiviral vector infec
−120 mV, 4.5 s pulse duration). The holding potential was−50 mV. Hyperpolarizing pulse
increments. The tail currents were recorded at +20 mV. (D) Western blot analysis of HCN
separate samples. Non-infected myocytes were used as a negative control. α-actins were usDiscrepancy in midpoint voltages of HCN2 and HCN4 expressed
mammalian cells existed in previous reports. Some reported a more
depolarized V0.5 for HCN2 than for HCN4 [21–23], while others
showed a more hyperpolarized V1/2 for HCN2 than for HCN4 [19,20].
This can be caused by many factors such as temperature (room versus
body temperature), expression vector, passages of cells, and endo-
genous proteins that may modulate the properties of HCN channels.
Under our experimental conditions, we observed a more depolarized
V1/2 for HCN2 than for HCN4. The difference, however, is less
signiﬁcant in comparison to the V1/2 for HCN2 and HCN4 expressed
in Xenopus oocytes.
To extend our studies to cardiomyocytes, we explored an idea
whether the interaction of HCN2 and HCN4 in myocytes might occur
even before the channel proteins are synthesized. We used lentivirus
as an effective delivery system, shown in the recent studies for
selectively manipulation of ion channel expression in cardiomyocytes
(e.g., see ref. [32]), to either down-regulate HCN2 mRNA in neonatal
rat ventricular myocytes by an shRNA-directed approach or up-
regulate HCN4 mRNA by overexpressing HCN4 in adult rat ventricular
myocytes. The reason for altering the HCN mRNA in rat at different
ages is that HCN2 and HCN4 expression levels are relatively higher in
neonatal and lower in adult rat ventricles [13]. It would be more
feasible to inhibit the high mRNA expression in neonatal ventricles
and enhance the low mRNA expression in adult ventricles. Althoughtion (C) and with HCN4 overexpression (B) (inset: 4 mM Cs blockade of If recorded at
s for 4.5 s (A, C) or variable durations (B) ranged from−70 mV to−140 mV in 10 mV
4 expression in adult rat ventricular myocytes overexpressing HCN4 repeated in three
ed as loading controls.
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HCN2 knockdownwas associated with a signiﬁcant decrease in HCN4
mRNA. Likewise, enhancing themRNA of HCN4 by overexpressionwas
linked to a dramatic increase in HCN2mRNA. Moreover, if we increase
the ratio of HCN2 and HCN4 mRNA by overexpressing HCN4 in
myocytes, we observed enhanced If activity that mimics that in
neonatal rat ventricular myocytes, a result similar to that we observed
in Xenopus oocytes. Finally, we conﬁrmed association of HCN2 and
HCN4 channels in rat adult ventricles using co-immunoprecipitation
experiments.
As it is always the case with unexpected observations, new
questions are raised as the underlying mechanisms for the
associated alteration of HCN2 and HCN4 mRNAs. The transcript
levels are controlled by the promoter activity. There are high
sequence similarity in HCN2 and HCN4 promoters [33]. From a
speculative viewpoint (since very little is known about gene
regulation for HCN channels), there might exist a feedback link
between the mRNA synthesis and the promoter activity for HCN
channel expression (e.g., [34]). Thus, changes in expression of one
isoform can affect the expression of the other. This speculation is
partially supported by the data showing that in HEK293 cells (no
endogenous HCN channels) HCN2-shRNA did not affect HCN4 mRNA
levels (Fig. 4D). In myocytes (both neonatal and adult) where there
are signiﬁcant expression of HCN2 and HCN4, HCN2-shRNA did
decrease HCN4 mRNA, but to a lesser degree (Fig. 4D) as compared
with HCN2 inhibition (Fig. 4C).
It is worth noting that the voltage-gated potassium channel, Kv1.5,
can produce homomeric channels at low concentration and hetero-
meric channels (with Kv1.4) at high concentration [35]. The ratio of
HCN2 over HCN4 mRNA in ventricles changes during development
[13]. Thus, the relative abundance of HCN2 and HCN4 might be
important in contributing to the assembly of HCN2/HCN4 hetero-
meric channels in different tissues. If true, the conditions under which
the HCN2 and HCN4 can form the heteromeric channels in vivo are not
only signiﬁcant in understanding of tissue-speciﬁc properties of If, but
also important in the novel therapeutic development of biological
pacemaker (e.g., see [36]). In addition, different levels of HCN2 and
HCN4 transcripts provide an additional mechanism that heteromeric
channels can be formed with different stoichiometry. Having both
homomeric and heteromeric channels may have a unique advantage
in the modulation of the expressed current in response to various
environmental demands.
A recent report on microRNA inhibition of HCN has shown that the
cardiac muscle-speciﬁc miR-1 can suppress both HCN2 and HCN4
mRNA [37]. It may provide future direction in themechanistic study of
associated changes in HCN2 and HCN4 mRNA. Due to the non-speciﬁc
feature of miR-1 which targeted the 3′ untranslated regions of both
HCN2 and HCN4, it remains a possibility that when one isoform of
HCN is altered, it changes the expression level of miR-1, which in turn,
affects the expression level of the other isoforms of HCN.
Part of the results was previously published in an abstract form in
Experimental Biology 2007 [30].
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